Bicycle Therapeutics plc (BCYC) Earnings History
Annual and quarterly earnings data from 2016 to 2025
Loading earnings history...
BCYC EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
BCYC Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 100.0% | -341.3% | -301.7% |
| 2024 | -390.3% | -595.0% | -479.2% |
| 2023 | -480.1% | -704.1% | -669.7% |
| 2022 | 100.0% | -806.6% | -779.3% |
| 2021 | 100.0% | -561.0% | -571.2% |
Download Data
Export BCYC earnings history in CSV or JSON format
Free sign-in required to download data
Bicycle Therapeutics plc (BCYC) Earnings Overview
As of May 8, 2026, Bicycle Therapeutics plc (BCYC) reported trailing twelve-month net income of -$219M, reflecting -9.0% year-over-year growth. The company earned $-3.14 per diluted share over the past four quarters, with a net profit margin of -301.7%.
Looking at the long-term picture, BCYC's historical earnings data spans multiple years. The company achieved its highest annual net income of -$14M in fiscal 2016.
Bicycle Therapeutics plc is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PEPG (-$90M net income), CYCN (-$4M net income, -170.1% margin), PRAX (-$327M net income), BCYC has comparable earnings metrics. Compare BCYC vs PEPG →
BCYC Earnings vs Peers
Earnings metrics vs comparable public companies
BCYC Historical Earnings Data (2016–2025)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$219M | -29.5% | -$248M | $-3.16 | -301.7% | -341.3% |
| 2024 | -$169M | +6.4% | -$210M | $-2.90 | -479.2% | -595.0% |
| 2023 | -$181M | -60.3% | -$190M | $-5.08 | -669.7% | -704.1% |
| 2022 | -$113M | -68.7% | -$117M | $-3.80 | -779.3% | -806.6% |
| 2021 | -$67M | -31.0% | -$66M | $-2.67 | -571.2% | -561.0% |
| 2020 | -$51M | -66.7% | -$52M | $-2.66 | -491.0% | -500.1% |
| 2019 | -$31M | -40.1% | -$26M | $-2.77 | -221.8% | -190.6% |
| 2018 | -$22M | -34.4% | -$22M | $-1.64 | -306.1% | -304.7% |
| 2017 | -$16M | -20.3% | -$16M | $-1.22 | -789.3% | -787.0% |
| 2016 | -$14M | - | -$13M | $-0.76 | - | - |
See BCYC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BCYC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BCYC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBCYC — Frequently Asked Questions
Quick answers to the most common questions about buying BCYC stock.
Is BCYC growing earnings?
BCYC EPS fell to $-3.14, with earnings declining -9.0%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-219M.
What are BCYC's profit margins?
Bicycle Therapeutics plc net margin is -301.7%, with operating margin at -341.3%. Below-average margins reflect competitive or cost pressures.
How consistent are BCYC's earnings?
BCYC earnings data spans 2016-2025. The declining earnings trend is -9.0% YoY. Historical data enables comparison across business cycles.